Postoperative Follow-Up for Patients with Non-Small Cell Lung Cancer

被引:17
|
作者
Nakamura, Ryota [2 ]
Kurishima, Koichi [3 ]
Kobayashi, Naohiro [2 ]
Ishikawa, Shigemi [2 ]
Goto, Yukinobu [2 ]
Sakai, Mitsuaki [2 ]
Onizuka, Masataka [2 ]
Ishikawa, Hiroichi [4 ]
Satoh, Hiroaki [1 ,3 ]
Hizawa, Nobuyuki [3 ]
Sato, Yukio [2 ]
机构
[1] Univ Tsukuba, Mito Med Ctr, Dept Internal Med, Mito, Ibaraki 3100015, Japan
[2] Univ Tsukuba, Div Cardiovasc Thorac Surg, Mito, Ibaraki 3100015, Japan
[3] Univ Tsukuba, Inst Clin Med, Mito, Ibaraki 3100015, Japan
[4] Tsukuba Med Ctr, Div Resp Med, Tsukuba, Ibaraki, Japan
来源
ONKOLOGIE | 2010年 / 33卷 / 1-2期
关键词
Non-small cell lung cancer; Surgery; Postoperative; Follow-up; Prognosis; SURVIVAL; QUALITY; CARE; SURVEILLANCE; COMORBIDITY; PHYSICIANS; RESECTION; SURGERY; INDEX; SCORE;
D O I
10.1159/000264623
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: It is unclear whether postoperative follow-up by thoracic surgeons or chest physicians for non-small cell lung cancer (NSCLC) alters survival. Patients and Methods: The charts of 1,398 NSCLC patients, diagnosed between 1980 and 2008, were reviewed. Prognostic factors contained therein were evaluated using univariate and multivariate analyses. Patients were divided into 2 groups according to the doctor in charge of their postoperative follow-up: the thoracic surgeon group and the chest physician group. The doctors in charge of following up the patients were also analyzed for prognostic significance. Results: In the univariate and multivariate analyses, age 65 years or younger, female sex, early pathological stage, Charlson Index score of 0-1, absence of adjuvant therapy, and follow-up by a chest physician were significantly favorable prognostic factors. Examined overall, NSCLC patients in the chest physician group had longer survival than those in the thoracic surgeon group. The difference in survival of patients with advanced disease was also statistically significant between these 2 groups. Conclusions: Our results indicate that early detection of asymptomatic disease by regular follow-up including chest computed tomography scan may improve the chance of treatment with curative intent and thus may increase survival, irrespective of the doctor in charge of follow-up.
引用
收藏
页码:14 / 18
页数:5
相关论文
共 50 条
  • [11] The 5-year Survival Rate of Postoperative Non-small Cell Lung Cancer Patients with Two Different Follow-up Patterns
    Sun, D.
    Chen, P.
    Li, X.
    Hu, J.
    Xu, L.
    Fu, X.
    Liu, Y.
    Liu, D.
    Liu, L.
    Zhang, X.
    He, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S860 - S861
  • [13] Follow-up in non-small-cell lung cancer
    Rothschild S.I.
    Lardinois D.
    Bremerich J.
    Tamm M.
    Bubendorf L.
    Papachristofilou A.
    Stoll H.
    Zippelius A.
    memo - Magazine of European Medical Oncology, 2014, 7 (2) : 97 - 101
  • [14] Follow-up results of combined treatment of non-small lung cancer
    Jackevicius, A
    Cicenas, S
    Piscikas, D
    Aleknavicius, E
    Ciceniene, A
    LUNG CANCER, 2004, 45 : S55 - S56
  • [15] Relevance of circulating biomarkers for the therapy monitoring and follow-up investigations in patients with non-small cell lung cancer
    Barak, Vivian
    Holdenrieder, Stefan
    Nisman, Benjamin
    Stieber, Petra
    CANCER BIOMARKERS, 2010, 6 (3-4) : 191 - 196
  • [16] Results of Long-Term Follow-Up of Patients With Completely Resected Non-Small Cell Lung Cancer
    Endo, Chiaki
    Sakurada, Akira
    Notsuda, Hirotsugu
    Noda, Masafumi
    Hoshikawa, Yasushi
    Okada, Yoshinori
    Kondo, Takashi
    ANNALS OF THORACIC SURGERY, 2012, 93 (04): : 1061 - 1069
  • [17] The Role of MonoTotal in the Primary Diagnosis, Prognosis and Follow-up of Patients with Non-small Cell Lung Cancer (NSCLC)
    Prazakova, Marketa
    Vrzalova, Jindra
    Maria Auge, Josep
    Safranek, Jarmil
    Topolcan, Ondrej
    Fuchsova, Radka
    Spisakova, Marketa
    Svobodova, Sarka
    Holubec, Lubos, Jr.
    Pesta, Martin
    ANTICANCER RESEARCH, 2011, 31 (09) : 3107 - 3112
  • [18] Ten-Year Follow-Up of Lung Cancer Patients with Resected Stage IA Invasive Non-Small Cell Lung Cancer
    Li, Xiongfei
    Fan, Fanfan
    Yang, Zijiang
    Huang, Qingyuan
    Fu, Fangqiu
    Zhang, Yang
    Chen, Haiquan
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (09) : 5729 - 5737
  • [19] Three years follow-up of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer
    Ji, Wenhao
    Jiang, Youhua
    Li, Yuetong
    Mao, Weimin
    Teng, Lisong
    NEOPLASMA, 2024, 71 (01) : 88 - 97
  • [20] Follow-Up Update of Molecular Residual Disease in Localized Non-Small Cell Lung Cancer
    Zhang, J-T
    Gao, X.
    Liu, S-Y
    Jiao, Z.
    Dong, S.
    Pan, Y.
    Zhou, Q.
    Zhong, W-Z
    Yang, X-N
    Yi, X.
    Wu, Y-L
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S117 - S117